Wall Street Journal5mon
ResMed Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Nasdaq7d
ResMed's Q1 2025 Earnings: What to Expect
Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...
USA Today2mon
What’s the difference between OEM and aftermarket parts?
OEM parts are often more reliable and more expensive than aftermarket parts. Aftermarket parts are more widely available and cheaper than OEM parts. Whether an OEM or aftermarket part is best ...
Morningstar21d
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...
Tesla, General Motors, AT&T, Western Digital, and More Stocks to Watch This Week
Third-quarter earnings reports from Nucor, SAP, General Motors, Lockheed Martin, Verizon, AT&T, Coca-Cola, Newmont, UPS, and ...
Kiplinger3mon
Five Stocks With Solid Growth History and a Promising Outlook
This auto parts retailer has reported consistently increasing ... implying a potential 18% gain from the stock’s recent close. ResMed (RMD, $206). The world’s largest manufacturer of breathing ...
The Best Performing S&P 500 Stocks Over the Past 30 Years Might Surprise You
ResMed's core business involves devices that ... essential pool maintenance items such as chemicals and replacement parts, as ...
The Australian21d
ResMed’s 2030 strategy for more product lines plus reasearch and development
Sleep apnoea devices giant ResMed wants to hit high single-digit revenue growth over the next five years broadening its product range for insomnia and COPD sufferers. The US headquartered company ...
Motley Fool Australia20d
500 million reasons why ResMed shares are charging higher today
Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...
Why your share portfolio is like a footy team (and 13 stocks to play)
Just as a team needs players with different skills and roles, so too does an investment portfolio. Brian Han of Morningstar ...
CNN1y
ResMed Inc.
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...
The Australian Financial Review8d
ResMed Inc.
Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...